{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T13:55:50Z","timestamp":1772978150833,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s11095-010-0182-y","type":"journal-article","created":{"date-parts":[[2010,6,17]],"date-time":"2010-06-17T20:37:30Z","timestamp":1276807050000},"page":"1837-1847","source":"Crossref","is-referenced-by-count":69,"title":["Microneedle-Based Transcutaneous Immunisation in Mice with N-Trimethyl Chitosan Adjuvanted Diphtheria Toxoid Formulations"],"prefix":"10.1007","volume":"27","author":[{"given":"Suzanne M.","family":"Bal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon F. A.","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Jiskoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joke A.","family":"Bouwstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,6,18]]},"reference":[{"key":"182_CR1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1586\/14760584.7.9.1329","volume":"7","author":"JA Mikszta","year":"2008","unstructured":"Mikszta JA, Laurent PE. Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook. Exp Rev Vaccines. 2008;7:1329\u201339.","journal-title":"Exp Rev Vaccines."},{"key":"182_CR2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archpediatrics.2009.35","volume":"163","author":"M Ipp","year":"2009","unstructured":"Ipp M, Parkin PC, Lear N, Goldbach M, Taddio A. Order of vaccine injection and infant pain response. Arch Pediat Adol Med. 2009;163:469\u201372.","journal-title":"Arch Pediat Adol Med."},{"key":"182_CR3","unstructured":"Immunization safety. www.who.int\/immunization_safety\/safe_injections\/en\/ ."},{"key":"182_CR4","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1073\/pnas.91.20.9519","volume":"91","author":"E Raz","year":"1994","unstructured":"Raz E, Carson DA, Parker SE, Parr TB, Abai AM, Aichinger G, et al. Intradermal gene immunization\u2014The possible role of DNA uptake in the induction of cellular-immunity to viruses. Proc Natl Acad Sci U S A. 1994;91:9519\u201323.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"182_CR5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0167-5699(93)90062-P","volume":"14","author":"JD Bos","year":"1993","unstructured":"Bos JD, Kapsenberg ML. The skin immune-system\u2014progress in cutaneous biology. Immunol Today. 1993;14:75\u20138.","journal-title":"Immunol Today"},{"key":"182_CR6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nri1310","volume":"4","author":"TS Kupper","year":"2004","unstructured":"Kupper TS, Fuhlbrigge RC. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol. 2004;4:211\u201322.","journal-title":"Nat Rev Immunol."},{"key":"182_CR7","doi-asserted-by":"crossref","first-page":"6755","DOI":"10.1016\/j.vaccine.2007.06.066","volume":"25","author":"RB Belshe","year":"2007","unstructured":"Belshe RB, Newman FK, Wilkins K, Graham IL, Babusis E, Ewell M, et al. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine. 2007;25:6755\u201363.","journal-title":"Vaccine."},{"key":"182_CR8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1086\/590434","volume":"198","author":"D Holland","year":"2008","unstructured":"Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis. 2008;198:650\u20138.","journal-title":"J Infect Dis."},{"key":"182_CR9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cimid.2007.07.015","volume":"31","author":"B Combadiere","year":"2008","unstructured":"Combadiere B, Mahe B. Particle-based vaccines for transcutaneous vaccination. Comp Immunol Microb. 2008;31:293\u2013315.","journal-title":"Comp Immunol Microb."},{"key":"182_CR10","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/jps.21523","volume":"98","author":"JH Wilson-Welder","year":"2009","unstructured":"Wilson-Welder JH, Torres MP, Kipper MJ, Mallapragada SK, Wannemuehler MJ, Narasimhan B. Vaccine adjuvants: current challenges and future approaches. J Pharm Sci. 2009;98:1278\u2013316.","journal-title":"J Pharm Sci."},{"key":"182_CR11","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/sj.jid.5700226","volume":"126","author":"A Vogt","year":"2006","unstructured":"Vogt A, Combadiere B, Hadam S, Stieler KM, Lademann J, Schaefer H, et al. 40\u00a0nm, but not 750 or 1, 500\u00a0nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol. 2006;126:1316\u201322.","journal-title":"J Invest Dermatol."},{"key":"182_CR12","doi-asserted-by":"crossref","first-page":"6818","DOI":"10.1016\/j.vaccine.2007.05.064","volume":"25","author":"M Amidi","year":"2007","unstructured":"Amidi M, Pellikaan HC, Hirschberg H, de Boerd AH, Crommelin DJA, Hennink WE, et al. Diphtheria toxoid-containing microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs. Vaccine. 2007;25:6818\u201329.","journal-title":"Vaccine."},{"key":"182_CR13","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s11095-009-9845-y","volume":"26","author":"N Hagenaars","year":"2009","unstructured":"Hagenaars N, Mastrobattista E, Verheul R, Mooren I, Glansbeek H, Heldens J, et al. Physicochemical and Immunological Characterization of N, N, N-Trimethyl chitosan-coated whole inactivated influenza virus vaccine for intranasal administration. Pharm Res. 2009;26:1353\u201364.","journal-title":"Pharm Res."},{"key":"182_CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2009.05.011","volume":"138","author":"B Slutter","year":"2009","unstructured":"Slutter B, Plapied L, Fievez V, Sande MA, des Rieux A, Schneider Y-J, et al. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination. J Control Release. 2009;138:113\u201321.","journal-title":"J Control Release"},{"key":"182_CR15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jconrel.2009.11.018","volume":"142","author":"SM Bal","year":"2010","unstructured":"Bal SM, Sl\u00fctter B, van Riet E, Kruithof AC, Ding Z, Kersten GFA, et al. Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations. J Control Release. 2010;142:374\u201383.","journal-title":"J Control Release"},{"key":"182_CR16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.vaccine.2006.06.086","volume":"25","author":"M Amidi","year":"2007","unstructured":"Amidi M, Romeijn SG, Verhoef JC, Junginger HE, Bungener L, Huckriede A, et al. N-Trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model. Vaccine. 2007;25:144\u201353.","journal-title":"Vaccine"},{"key":"182_CR17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2007.05.025","volume":"121","author":"W Boonyo","year":"2007","unstructured":"Boonyo W, Junginger HE, Waranuch N, Polnok A, Pitaksuteepong T. Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration. J Control Release. 2007;121:168\u201375.","journal-title":"J Control Release"},{"key":"182_CR18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.0022-202X.2005.23668.x","volume":"125","author":"PM Elias","year":"2005","unstructured":"Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol. 2005;125:183\u2013200.","journal-title":"J Invest Dermatol"},{"key":"182_CR19","unstructured":"Gerstel MS, Place VA. Drug delivery device, US, 1976."},{"key":"182_CR20","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1021\/js980042+","volume":"87","author":"S Henry","year":"1998","unstructured":"Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci. 1998;87:922\u20135.","journal-title":"J Pharm Sci."},{"key":"182_CR21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.vaccine.2008.10.077","volume":"27","author":"P Damme Van","year":"2009","unstructured":"Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, Almagor Y, Sharon O, Levin Y. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine. 2009;27:454\u20139.","journal-title":"Vaccine"},{"key":"182_CR22","doi-asserted-by":"crossref","first-page":"e4773","DOI":"10.1371\/journal.pone.0004773","volume":"4","author":"DG Koutsonanos","year":"2009","unstructured":"Koutsonanos DG, del Pilar Martin M, Zarnitsyn VG, Sullivan SP, Compans RW, Prausnitz MR, et al. Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One. 2009;4:e4773.","journal-title":"PLoS One"},{"key":"182_CR23","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.vaccine.2005.09.049","volume":"24","author":"G Widera","year":"2006","unstructured":"Widera G, Johnson J, Kim L, Libiran L, Nyam K, Daddona PE, et al. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine. 2006;24:1653\u201364.","journal-title":"Vaccine"},{"key":"182_CR24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1013607400040","volume":"19","author":"JA Matriano","year":"2002","unstructured":"Matriano JA, Cormier M, Johnson J, Young WA, Buttery M, Nyam K, et al. Macroflux (R) microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm Res. 2002;19:63\u201370.","journal-title":"Pharm Res."},{"key":"182_CR25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejps.2008.06.016","volume":"35","author":"SM Bal","year":"2008","unstructured":"Bal SM, Caussin J, Pavel S, Bouwstra JA. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci. 2008;35:193\u2013202.","journal-title":"Eur J Pharm Sci."},{"key":"182_CR26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AJP.0b013e31816778f9","volume":"24","author":"HS Gill","year":"2008","unstructured":"Gill HS, Denson DD, Burris BA, Prausnitz MR. Effect of microneedle design on pain in human volunteers. Clin J Pain. 2008;24:585\u201394.","journal-title":"Clin J Pain"},{"key":"182_CR27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2009.01.025","volume":"136","author":"Z Ding","year":"2009","unstructured":"Ding Z, Verbaan FJ, Bivas-Benita M, Bungener L, Huckriede A, van den Berg DJ, et al. Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB\/c mice. J Control Release. 2009;136:71\u20138.","journal-title":"J Control Release"},{"key":"182_CR28","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s11095-009-9874-6","volume":"26","author":"Z Ding","year":"2009","unstructured":"Ding Z, Van Riet E, Romeijn S, Kersten GFA, Jiskoot W, Bouwstra JA. Immune modulation by adjuvants combined with diphtheria toxoid administered topically in BALB\/c Mice after microneedle array pretreatment. Pharm Res. 2009;26:1635\u201343.","journal-title":"Pharm Res."},{"key":"182_CR29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.vaccine.2003.08.003","volume":"22","author":"B Metz","year":"2003","unstructured":"Metz B, Jiskoot W, Hennink WE, Crommelin DJA, Kersten GFA. Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines. Vaccine. 2003;22:156\u201367.","journal-title":"Vaccine"},{"key":"182_CR30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2008.02.009","volume":"128","author":"FJ Verbaan","year":"2008","unstructured":"Verbaan FJ, Bal SM, van den Berg DJ, Dijksman JA, van Hecke M, Verpoorten H, et al. Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method. J Control Release. 2008;128:80\u20138.","journal-title":"J Control Release"},{"key":"182_CR31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-1157(74)90016-X","volume":"2","author":"K Miyamura","year":"1974","unstructured":"Miyamura K, Tajiri E, Ito A, Murata R, Kono R. Micro cell-culture method for determination of dihptheria-toxin and antitoxin and antitoxin titers using vero cells 2. Comparison with rabbit skin method and practical application for sero-epidemiological studies. J Biol Stand. 1974;2:203\u20139.","journal-title":"J Biol Stand."},{"key":"182_CR32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/intimm\/5.8.885","volume":"5","author":"JT Collins","year":"1993","unstructured":"Collins JT, Dunnick WA. Germline transcripts of the murine immunoglobulin gamma 2a gene: structure and induction by IFN-gamma. Int Immunol. 1993;5:885\u201391.","journal-title":"Int Immunol."},{"key":"182_CR33","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/eji.1830200520","volume":"20","author":"E Severinson","year":"1990","unstructured":"Severinson E, Fernandez C, Stavnezer J. Induction of germ-line immunoglobulin heavy chain transcripts by mitogens and interleukins prior to switch recombination. Eur J Immunol. 1990;20:1079\u201384.","journal-title":"Eur J Immunol."},{"key":"182_CR34","doi-asserted-by":"crossref","unstructured":"Ding Z, Bal SM, Hahn T, Romeijn S, Kersten GFA, Jiskoot W, et al. Transcutaneous immunization studies in mice using diphtheria toxoid-loaded vesicle formulations and a microneedle array. Pharm Res. In Press.","DOI":"10.1007\/s11095-010-0093-y"},{"key":"182_CR35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2004.06.015","volume":"99","author":"R Alvarez-Rom\u00e1n","year":"2004","unstructured":"Alvarez-Rom\u00e1n R, Naik A, Kalia YN, Guy RH, Fessi H. Skin penetration and distribution of polymeric nanoparticles. J Control Release. 2004;99:53\u201362.","journal-title":"J Control Release"},{"key":"182_CR36","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/sj.jid.5700733","volume":"127","author":"B Baroli","year":"2007","unstructured":"Baroli B, Ennas MG, Loffredo F, Isola M, Pinna R, Lopez-Quintela MA. Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol. 2007;127:1701\u201312.","journal-title":"J Invest Dermatol."},{"key":"182_CR37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2006.10.019","volume":"66","author":"J Lademann","year":"2007","unstructured":"Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavi U, Luengo J, et al. Nanoparticles\u2014An efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm. 2007;66:159\u201364.","journal-title":"Eur J Pharm Biopharm."},{"key":"182_CR38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijpharm.2003.10.038","volume":"275","author":"AK Kohli","year":"2004","unstructured":"Kohli AK, Alpar HO. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. Int J Pharm. 2004;275:13\u20137.","journal-title":"Int J Pharm."},{"key":"182_CR39","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijpharm.2007.08.022","volume":"350","author":"L Sheihet","year":"2008","unstructured":"Sheihet L, Chandra P, Batheja P, Devore D, Kohn J, Michniak B. Tyrosine-derived nanospheres for enhanced topical skin penetration. Int J Pharm. 2008;350:312\u20139.","journal-title":"Int J Pharm."},{"key":"182_CR40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0005-2736(99)00176-5","volume":"1461","author":"BAI Bergh van den","year":"1999","unstructured":"van den Bergh BAI, Vroom J, Gerritsen H, Junginger HE, Bouwstra JA. Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two-photon excitation microscopy. BBA-Biomembranes. 1999;1461:155\u201373.","journal-title":"BBA-Biomembranes"},{"key":"182_CR41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0168-3659(03)00202-5","volume":"90","author":"PL Honeywell-Nguyen","year":"2003","unstructured":"Honeywell-Nguyen PL, Groenink HWW, de Graaff AM, Bouwstra JA. The in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application. J Control Release. 2003;90:243\u201355.","journal-title":"J Control Release"},{"key":"182_CR42","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.0022-202X.2004.23441.x","volume":"123","author":"PL Honeywell-Nguyen","year":"2004","unstructured":"Honeywell-Nguyen PL, Gooris GS, Bouwstra JA. Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. J Invest Dermatol. 2004;123:902\u201310.","journal-title":"J Invest Dermatol."},{"key":"182_CR43","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijpharm.2008.08.040","volume":"366","author":"SA Coulman","year":"2009","unstructured":"Coulman SA, Anstey A, Gateley C, Morrissey A, McLoughlin P, Allender C, et al. Microneedle mediated delivery of nanoparticles into human skin. Int J Pharm. 2009;366:190\u2013200.","journal-title":"Int J Pharm."},{"key":"182_CR44","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/IAI.00797-07","volume":"76","author":"P Stickings","year":"2008","unstructured":"Stickings P, Peyre M, Coombes L, Muller S, Rappuoli R, Del Giudice G, et al. Transcutaneous immunization with cross-reacting material CRM197 of diphtheria toxin boosts functional antibody levels in mice primed parenterally with adsorbed diphtheria toxoid vaccine? Infect Immun. 2008;76:1766\u201373.","journal-title":"Infect Immun."},{"key":"182_CR45","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1016\/j.vaccine.2006.05.014","volume":"24","author":"I Skountzou","year":"2006","unstructured":"Skountzou I, Quan F-S, Jacob J, Compans RW, Kang S-M. Transcutaneous immunization with inactivated influenza virus induces protective immune responses. Vaccine. 2006;24:6110\u20139.","journal-title":"Vaccine."},{"key":"182_CR46","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.vaccine.2003.09.012","volume":"22","author":"EA McNeela","year":"2004","unstructured":"McNeela EA, Jabbal-Gill I, Illum L, Pizza M, Rappuoli R, Podda A, et al. Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan. Vaccine. 2004;22:909\u201314.","journal-title":"Vaccine"},{"key":"182_CR47","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.21.120601.141045","volume":"21","author":"RM Zinkernagel","year":"2003","unstructured":"Zinkernagel RM. On natural and artificial vaccinations. Annu Rev Immunol. 2003;21:515\u201346.","journal-title":"Annu Rev Immunol."},{"key":"182_CR48","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<769::AID-IMMU769>3.0.CO;2-H","volume":"28","author":"H Kondo","year":"1998","unstructured":"Kondo H, Ichikawa Y, Imokawa G. Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response. Eur J Immunol. 1998;28:769\u201379.","journal-title":"Eur J Immunol."},{"key":"182_CR49","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.4049\/jimmunol.156.11.4079","volume":"156","author":"LF Wang","year":"1996","unstructured":"Wang LF, Lin JY, Hsieh KH, Lin RH. Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice. J Immunol. 1996;156:4079\u201382.","journal-title":"J Immunol."},{"key":"182_CR50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2567.2006.02401.x","volume":"119","author":"J Strid","year":"2006","unstructured":"Strid J, Callard R, Strobel S. Epicutaneous immunization converts subsequent and established antigen-specific T helper type 1 (Th1) to Th2-type responses. Immunology. 2006;119:27\u201335.","journal-title":"Immunology."},{"key":"182_CR51","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/eji.200425196","volume":"34","author":"J Strid","year":"2004","unstructured":"Strid J, Hourihane J, Kimber I, Callard R, Strobel S. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur J Immunol. 2004;34:2100\u20139.","journal-title":"Eur J Immunol."},{"key":"182_CR52","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.immuni.2008.07.013","volume":"29","author":"E Klechevsky","year":"2008","unstructured":"Klechevsky E, Morita R, Liu MC, Cao YY, Coquery S, Thompson-Snipes L, et al. Functional specializations of human epidermal langerhans cells and CD14(+) dermal dendritic cells. Immunity. 2008;29:497\u2013510.","journal-title":"Immunity"},{"key":"182_CR53","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1084\/jem.20071966","volume":"204","author":"LS Bursch","year":"2007","unstructured":"Bursch LS, Wang L, Igyarto B, Kissenpfennig A, Malissen B, Kaplan DH, et al. Identification of a novel population of Langerin(+) dendritic cells. J Exp Med. 2007;204:3147\u201356.","journal-title":"J Exp Med."},{"key":"182_CR54","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1084\/jem.20071733","volume":"204","author":"F Ginhoux","year":"2007","unstructured":"Ginhoux F, Collin MP, Bogunovic M, Abel M, Leboeuf M, Helft J, et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J Exp Med. 2007;204:3133\u201346.","journal-title":"J Exp Med."},{"key":"182_CR55","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20071724","volume":"204","author":"LF Poulin","year":"2007","unstructured":"Poulin LF, Henri S, de Bovis B, Devilard E, Kissenpfennig A, Malissen B. The dermis contains langerin\u2009+\u2009dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med. 2007;204:3119\u201331.","journal-title":"J Exp Med."},{"key":"182_CR56","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jconrel.2010.01.007","volume":"143","author":"B Slutter","year":"2010","unstructured":"Slutter B, Soema PC, Ding Z, Verheul R, Hennink W, Jiskoot W. Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen. J Control Release. 2010;143:207\u201314.","journal-title":"J Control Release"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s11095-010-0182-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T16:59:47Z","timestamp":1685638787000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-010-0182-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,18]]},"references-count":56,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["182"],"URL":"https:\/\/doi.org\/10.1007\/s11095-010-0182-y","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,18]]}}}